BioData EU 2018 Agenda

 

 

Basel, 28 - 29 November 2018

Schedule

Create your personal agenda –check the favourite icon

Nov 2808:45
Conference pass

Chair’s opening remarks (Government of Switzerland)

Keynotes
Christoph Brutschin, Member of the Executive Council of the Canton of Basel-Stadt and Head of the Department of Economic and Social Affairs Canton of Basel-Stadt
Nov 2808:50
Conference pass

Keynote opening address

Keynotes
Abel Archundia, Global Head of IT Pharma, Bayer Business Services
Abel Archundia, Global Head of IT Pharma, Bayer Business Services
Nov 2809:10
Conference pass

Global Data Sharing and Collaboration

Keynotes
Mona Siddiqui, Chief Data Officer, United States Department of Health and Human Services
Nov 2809:30
Conference pass

Reimagining medicine with data and digital

Keynotes
Bertrand Bodson, Chief Digital Officer, Novartis
Bertrand Bodson, Chief Digital Officer, Novartis
Nov 2810:00
Conference pass

Data Lives Forever

Keynotes
Wim De Wispelaere, VP Technology & Advanced Development, Western Digital
Nov 2811:20
Conference pass

Enabling healthcare and precision medicine with AI

Keynotes
Marco Marcella, Head of Unit, eHealth, Well-being, and Ageing, EU Commission
Nov 2811:40
Conference pass

Round Tables

Keynotes
Round Table A: Using Electronic Medical Record (EMR) data to inform big pharma’s drug discovery, development, and marketing processes
Nicholas Kelley, Research Investigator, Genomics, Novartis Institutes
Round Table B: Agile Data Management – Challenges, emerging practices and way forward
Round Table C: Data Management and Democratisation
Olivier Roche, Global Data Quality Coordinator, Biology workflow team leader, Roche
Moritz Gilsdorf, Senior Scientific Software Engineer, Roche
Round Table D: How to improve efficiency in machine learning producibility- Western Digital
Round Table F: Navigating Real World Data & Applied Analytics
Gabriel Eichler, Workstream Lead, Kraft Precision Medicine Accelerator, Harvard Business School, Harvard Business School
Round Table G: Using RWD across borders
Eunice Jung, Associate Director – Medical Evidence, Research & Innovation, Biogen
Round Table H: Examining developments on data privacy
Ekaterina Sidorova, Head of Information Risk Management, Lonza
Lee Parker, Data Privacy Director, Biogen
Maria Chiara Atzori, Head Data Privacy Switzerland, Novartis
Nicola Orlandi, Head of Data Privacy Pharma, Novartis
Round Table I: Learnings and results from large-scale investments in data across the pharmaceutical R&D chain
Greg Temesi, Director, R, Merck
Jens Christensen, Director, Merck
Round Table J: Standards for clinical trial operational data sharing across the industry
Davide Franco, Director, Strategy and Operations, Predictive Analytics and Design, Novartis, Novartis
Gernot Weber, Global Program Director, Predictive Analytics And Design, Novartis
Robert Mcgregor, Global Program Director, Predictive Analytics And Design, Novartis
Round Table K: Translational Oncology Informatics
Ronghua Chen, Director of Scientific Informatics, R&D IT, Merck
Round Table L: Examining device-based data capture and analytics
Steffen Roellinger, SVP – Head Portfolio & Operations of Clinical Operations, Pharma R&D, Bayer
Round Table M: Blockchain and Health
Lars Greiffenberg, Director Information Research, Library Sciences and Academic Partnerships, Abbvie Germany
Round Table N: Artificial Intelligence and Deep Learning in Healthcare and Life Sciences
Elia Stupka, Senior Director, Health Catalyst
Round Table O: Is legacy IT preventing you from making the next drug discovery?
Murat Vurucu, Managing Director and Co-Founder, Latentine
Round Table P: Sharing clinical data
Round Table Q: Wellcome Roundtable:Unlocking the Potential of Data to Improve Health for Everyone -What should Wellcome do about Data?
Nick Scott-Ram, VP of Strategic and Commercial Development, Sensyne Health
Chantal Wood, Programme Manager - Data for Science and Health, Wellcome Trust
Lena Granovsky, Director, Analytics and Big Data, Teva Pharmaceuticals
Nicola Perrin, Head, Data for Science and Health priority, Wellcome Trust
Round Table R: Applications of RNA-seq data to drug discovery
Shanrong Zhao, Director, Computational Biology and Bioinformatics,Worldwide R&D, Pfizer
Round Table S: Accelerating life sciences discovery with machine learning, and lessons learned along the way
Philip Nelson, Director, Software Engineering, Google Inc
Round Table T: Data standards, ontologies and controlled vocabularies
Peter Groenen, Head Of Translational Science, Idorsia
Round Table U: Digital Clinical Trials ...... moving to the connected future for patients, study investigators and CROs’
Jill Ede, RDI Solution Delivery Lead, Astra Zeneca
Cassie Gregson, Clinical Operations IT Capability Lead, AstraZeneca
Liz Nevin, Senior IT Business Relationship Manager, Digital Therapeutics, AstraZeneca
Round Table V: Developing data/analysis commons in translational medicine
Round Table W: Analytics for Regulatory and Safety RWE and Epidemiology
Round Table X: Empowering the Person in a Health System: Evidence for Effectiveness
Indra Joshi, Digital Health and AI Clinical Lead, NHS England
Round Table Y: Sourcing, managing, analysing and tracking biomedical data including clinical, genomics, imaging and IoT in large scale collaborations.

Create your personal agenda –check the favourite icon

Nov 2912:05
Conference pass

Round Tables

Keynotes
Round Table A: AI for Drug Discovery - Investment Landscape
Dmitry Kaminskiy, Managing Partner, Deep Knowledge Ventures
Round Table B: Managing and analyzing large cohort studies in the cloud to enable clinical studies & translational research
Round Table C: GDPR
Alix Zollinger, Lead Data Scientist, Nestle Institute of Health Sciences
Greg Lefebvre, Genomic Data Science Team Lead, Nestle Institute of Health Sciences
Round Table E: Digital Endopoints and Validation
Ieuan Clay, Group Lead Digital Endpoints, Novartis
Round Table F: AI in Ageing Research and Longevity
Tina Woods, Founder, Collider Health
Round Table G: Best practices and lessons learned on linked data zooming in on large scale data integration, data visualization and data curation
Filip Pattyn, Scientific Lead, Ontoforce
Round Table H: Diagnostics & Data
Sebastien Lefebvre, Senior Director Data Analytics & Decision Support, Alexion Pharmaceuticals
Round Table I: Human Protein Atlas: Big data for human biology and precision medicine
Round Table J: Databiology
Round Table K: Digital Substudies- Big Data in Drug Discovery
Lena Granovsky, Director, Analytics and Big Data, Teva Pharmaceuticals
Round Table L: Applied Health Science Research to Improve Clinical Outcomes
Round Table M: Decentralized Trial Settings
Scott Askin, Digital Solutions Director, Digital Development, Portfolio, Strategy & Innovation (PS&I), Novartis Pharma
Round Table N: Empowering the Person in a Health System: Evidence for Effectiveness
Indra Joshi, Digital Health and AI Clinical Lead, NHS England
Round Table O: Datalake architecture for R&D
David Ficenec, Global Head of Architecture, R and D Information Systems and Information Technology, Takeda Pharmaceuticals U.S.A. Inc
Round Table P: Wellcome Roundtable: Unlocking the Potential of Data to Improve Health for Everyone -What should Wellcome do about Data?
Chantal Wood, Programme Manager - Data for Science and Health, Wellcome Trust
Nicola Perrin, Head, Data for Science and Health priority, Wellcome Trust
James Thomas, Chief Technology Officer, Wellcome Trust
Round Table Q: Using AI in Drug Development
Edward Painter, Founder & CEI, A2A Pharmaceuticsls
Round Table R: Computing at the Exascale – Developing large scale genomics and heath record architecture
Edmon Begoli, Chief Data Architect, MVP CHAMPION Principal Investigator, Oak Ridge National Laboratory (ORNL)
Round Table S: Title to be confirmed
Audrey Kauffmann, Oncology Bioinformatics Site Head, Novartis
Round Table T: Securing budget for organising data so its findable and usable
Martin Romacker, Data and Information Architect, Roche
Round Table V: Applications of RNA-seq data to drug discovery
Round Table W: Digital Healthcare: When is healthcare going to be digitalised
Jasmin Saric, Head of Digital Ideation and Scouting, BI X GmbH
Round Table X: Challenges in Data Curation and Quality
Round Table Y: Using prescriptive and predictive advanced analytics to mitigate risk and optimise increasingly complex clinical trials’
Liz Nevin, Senior IT Business Relationship Manager, Digital Therapeutics, AstraZeneca
Jill Ede, RDI Solution Delivery Lead, Astra Zeneca
Cassie Gregson, Clinical Operations IT Capability Lead, AstraZeneca
last published: 21/Nov/18 09:25 GMT

Sign Up for Event Updates

Contact us

To sponsor or exhibit contact:
Alistair Wilmot
+44 (0)207 092 1174

alistair.wilmot@terrapinn.com


To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com